Home » EMEA Releases Draft Guideline on Development of PTSD Drugs
EMEA Releases Draft Guideline on Development of PTSD Drugs
November 19, 2007
The European Medicines Agency (EMEA) has published a draft guideline on special marketing authorization considerations related to clinical trials of medicines for post-traumatic stress disorder (PTSD).
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor